Pfizer Inc. PFE
NYSE
Recommendation
Dividend Power Score
Day's Range
$28.95$29.38
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 09/27/2026 | 06/28/2026 | 03/29/2026 | 12/31/2025 | 09/28/2025 | |
|---|---|---|---|---|---|
| Revenue | 16.58B | 15.03B | 14.45B | 17.56B | 16.65B |
| Total Other Revenue | -- | -- | 1.00M | -- | -- |
| Total Revenue | 16.58B | 15.03B | 14.45B | 17.56B | 16.65B |
| Cost of Revenue | 3.84B | 3.66B | 3.41B | 5.07B | 3.98B |
| Gross Profit | 12.74B | 11.38B | 11.04B | 12.49B | 12.68B |
| SG&A Expenses | 3.12B | 3.26B | 2.84B | 3.74B | 3.09B |
| Depreciation & Amortization | 1.13B | 1.19B | 1.18B | 1.23B | 1.22B |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.05B | 10.84B | 9.88B | 13.35B | 10.78B |
| Operating Income | 5.54B | 4.19B | 4.57B | 4.20B | 5.88B |
| Income Before Tax | 3.39B | -653.00M | 3.17B | -1.64B | 3.33B |
| Income Tax Expenses | 134.00M | -407.00M | 461.00M | -2.00M | -216.00M |
| Earnings from Continuing Operations | 3.25B | -246.00M | 2.71B | -1.64B | 3.55B |
| Earnings from Discontinued Operations | -- | 8.00M | -13.00M | 0.00 | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -10.00M | -10.00M | -8.00M | -8.00M | -9.00M |
| Net Income | 3.24B | -248.00M | 2.69B | -1.65B | 3.54B |
| EBIT | 5.54B | 4.19B | 4.57B | 4.20B | 5.88B |
| EBITDA | 7.10B | 5.80B | 6.18B | 5.86B | 7.53B |
| EPS Basic | 0.57 | -0.04 | 0.47 | -0.29 | 0.62 |
| Normalized Basic EPS | 0.59 | 0.46 | 0.45 | 0.56 | 0.61 |
| EPS Diluted | 0.56 | -0.04 | 0.47 | -0.29 | 0.62 |
| Normalized Diluted EPS | 0.58 | 0.46 | 0.45 | 0.56 | 0.60 |
| Average Basic Shares Outstanding | 5.70B | 5.70B | 5.69B | 5.69B | 5.69B |
| Average Diluted Shares Outstanding | 5.75B | 5.70B | 5.73B | 5.69B | 5.71B |
| Dividend Per Share | 0.43 | 0.43 | 0.43 | 0.86 | 0.43 |
| Payout Ratio | 75.60% | -988.31% | 90.99% | -148.36% | 69.02% |